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Site Incidence Data Report for St. Cloud Hospital
The data below reflects the cancer care given at St. Cloud Hospital,
Coborn Cancer Center and the Alexandria Radiation Oncology Department.

Cancer Registry Statistics
Our service area
St. Cloud Hospital is located in the heart of Central Minnesota. Its primary service area
covers Stearns, Benton and Sherburne counties, with secondary service area extending
to 23 counties across Central Minnesota.
Coborn Cancer Center provides comprehensive care and an extensive range of treatment
options to support cancer patients and their families. We understand the importance of
receiving quality cancer care and treatment close to home, and provide services in many
Central Minnesota communities including St. Cloud, Alexandria, Glenwood, Little Falls,
Long Prairie, Melrose, Monticello, Paynesville and Sauk Centre.
Coborn Cancer Center is a strong community supporter giving back more than $372,496
last year through education, prevention and early detection events to meet the needs of
our community. These events included the CentraCare Health Family Farmers Market,
Relay for Life, various support groups and much more.

Array of services supporting cancer patients
Behavioral Health
Breast Center
Cancer Registry
Cancer Research
Center for Surgical Care
CentraCare Digestive Center
CentraCare Wound Center
Chemotherapy and Infusion Services
Gorecki Guest House

Hematology/Oncology
Home Care Services
Hospice Services
Hospitalist Program
Imaging Services
Inpatient Oncology
Integrative Therapies
Laboratory
Palliative Care

Pathology
Pharmacy
Radiation Oncology
Rehabilitation Services
Respiratory Care
Spiritual Care
Survivorship Services
Volunteer Services

		
ALL SITES
Head and Neck
Lip and Oral Cavity
Pharynx
Nasal/Paranasal Cavity
Salivary Glands
Larynx
Other Head and Neck
Digestive System
Esophagus
Stomach
Colon
Rectum
Anus/Anal Canal
Liver
Pancreas
Other Digestive
Respiratory System
Lung/Bronchus-Small Cell
Lung/Bronchus-Non Small Cell
Other Bronchus and Lung
Other Respiratory
Blood and Bone Marrow
Leukemia
Multiple Myeloma
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Other Hematopoietic
Bone
Connective/Soft Tissue
Skin
Melanoma
Other skin
Breast
Female Genital
Cervix Uteri
Corpus Uteri
Ovary
Vulva
Other Female Genital
Male Genital
Prostate
Testis
Other Male Genital
Urinary System
Bladder
Kidney/Renal
Other Urinary
Brain and CNS
Brain (Benign)
Brain (Malignant)
Other Brain and CNS
Endocrine
Thyroid
Other Endocrine
Unknown Primary
Other/Ill-defined Sites

2011
1603
49
11
21
2
4
11
0
253
15
21
87
41
3
12
44
30
220
35
169
10
6
160
47
25
5
66
17
2
4
35
34
1
290
60
4
38
14
2
2
279
271
7
1
129
59
66
4
51
1
35
15
53
45
8
15
3

2012
1526
50
14
19
1
4
12
0
250
13
13
80
39
5
12
64
24
243
40
194
5
4
183
52
29
11
66
25
0
8
42
37
5
264
53
5
33
10
2
3
176
164
8
4
117
55
56
6
66
2
28
36
49
45
4
14
11

2013
1579
43
13
12
1
4
12
1
294
13
24
101
52
4
10
69
21
224
31
187
3
3
163
31
33
13
67
19
3
5
43
40
3
311
55
2
27
24
1
1
171
154
12
5
141
61
73
7
47
1
23
23
56
42
14
18
5

2014
1556
55
20
15
2
6
12
0
279
17
21
83
37
6
15
70
30
224
22
193
4
5
146
54
21
5
52
14
2
13
32
29
3
278
69
4
46
17
1
1
166
157
8
1
167
83
77
7
54
0
26
28
43
35
8
21
7

2015
1619
46
13
19
1
3
10
0
280
20
22
74
38
3
21
69
33
211
42
163
4
2
175
54
25
11
74
11
2
7
45
41
4
278
53
0
35
15
1
2
222
205
10
7
188
104
77
7
51
3
31
17
38
36
2
14
9

Note: The increase in bladder and prostate cases in 2015 could be attributed to Adult & Pediatric Urology in
Sartell joining CentraCare Health in January 2015, resulting in an increase in prostate biopsies and bladder surgery
at St. Cloud Hospital and CentraCare Surgery Center.
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Welcome
Hilary Ufearo, MBBS

As we embark upon the presentation of our 30th edition of the
St. Cloud Hospital cancer report, we would like to pause and reflect
on what differentiates the Coborn Cancer Center from other
cancer programs. We are reminded of a frequently asked question,
“What is your vision for the Coborn Cancer Center?” The answer
to both is a fundamental belief that all we aspire to do is intricately
intertwined in the strength of our relationships, not only with
our patients, but with their families and their caregivers, as well
as members of their care team and community. Cancer will touch
each of our lives in a different way and at different times. Whether
we are personally afflicted or we are impacted by someone who
is going through cancer such as a loved one, a friend, a coworker,
a teacher or a mentor; cancer means something different to
every person.

Physician Section Director, Oncology
Hematology/Oncology

Sonya Wieber, MS, MBA
Section Director, Oncology

The full scope of a person’s journey with cancer cannot always
be told, but the courage and vigor for life they impart upon us is
easily one of the most profound demonstrations of strength we
may have the opportunity to experience. The focus of this year’s
annual report, as determined by the Cancer Care Center Board,
is on brain/central nervous system cancers which overall represents
a small fraction, less than 4 percent, of our newly diagnosed cases
each year. However, the complexity of treating such a disease
involves a myriad of considerations given the potential impact to
cognitive functioning and the necessary psychosocial support as
patients undergo rehabilitation.
As a comprehensive cancer program, we strive to meet the
patients’ needs therapeutically whether with chemotherapy or
radiation therapy. We also continuously assess where we are
and what we can do better to offer the supportive services our
patients need. It is through this ongoing commitment to being a
better partner to our health community that we find ourselves
in a unique position to not only treat our patients, but their
families and caregivers as well.

2
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The time spent listening to our patients and members of their care team tells
us we do a phenomenal job treating them physically, but once they are done
receiving their treatment, they need more support from us moving into the
next phase in their cancer journey. Their lives have been disrupted and we need
to provide the necessary resources to re-establish what their life will now look
like moving forward.
We introduced the Farmers Market as a part of our initiative to promote
healthier food options in our community and to raise awareness of the impact
healthy eating habits can have on cancer prevention. We will continue to
expand our efforts as we partner with BLEND (Better Living: Exercise and
Nutrition Daily) through the CentraCare Health Foundation as we strive to
diversify our target audience and reach those who have limited access
to healthy food.
The 41st annual Holly Ball event took place in December 2015. Donations
received through the Fund-a-Need campaign during this event are dedicated
to support Integrative Therapies to our patients at the Coborn Cancer Center
which includes acupuncture, acupressure, hand massage, Healing Touch and
aromatherapy. An RN integrative therapies specialist with specific training in
oncology began in April 2016. These services have been shown to decrease
side effects related to chemotherapy such as anxiety, fatigue and pain.
On behalf of the Cancer Care Center Board, we hope the enclosed material
will provide you with a synopsis of the direction we aim to move our program
which is not only a continuity of our clinical excellence and exemplary outcomes,
but a dedication to our holistic approach to healing. Please visit centracare.com
for a full menu of services available at Coborn Cancer Center.
Sincerely,

Sonya Wieber, MS, MBA
Section Director, Oncology

Hilary Ufearo, MBBS
Physician Section Director, Oncology
Hematology/Oncology

Kurt Otto
Vice President Operations,
Specialty Division

Thomas Schrup, MD
Physician Vice President,
Specialty Division

Continued Advancement
As executive co-leaders of the specialty division at St. Cloud Hospital, we
share responsibility for the supervision and oversight of our oncology services.
We support Coborn Cancer Center as they bring the organization’s
commitment to fulfilling the Triple Aim plus People into each and every patient’s
experience. This means keeping patients at the center of all we do as well as
our dedication to providing top-notch quality care and value-added services
in a manner which reflects the mission of our organization.
Executive leadership has formally accepted the proposal brought forward by
Coborn Cancer Center to become an integrated service line for cancer care
across CentraCare Health. This is important for our patients because it means
they can expect the same level of quality cancer care regardless of where they
receive their treatment. Our work continues as we move forward with a
steadfast commitment to the value our cancer program offers.
We look forward to planning our survivorship center which will be 100 percent
philanthropically supported. The Coborn Family Foundation announced their
$1-million gift in support of this work to make our vision become a reality.
On behalf of the providers, staff and patients of Coborn Cancer Center,
thank you to all who so graciously continue to support us!
30th Annual Cancer Report | Coborn Cancer Center
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A New Chapter
At age 47, Pam Schnettler was preparing for her oldest daughter’s graduation
party during Memorial weekend 2008. Through the hustle and bustle of her
long to-do list, things suddenly took an unexpected turn. During a trip to the
supermarket, Pam suddenly felt the grocery aisles caving in. She went home
to rest, which is the last thing she remembers that day. After being awakened
by her family and being in and out of consciousness, they called 911 and an
ambulance arrived soon after, at their home in Sartell.
After awakening in the Emergency Room, the physician and Pam’s husband, Greg,
told her she had a brain tumor. She then had a brain biopsy and MRI, which
showed it was cancer. After discussing her options with Harold Windschitl, MD,
and Hani Alkhatib, MD, the final decision was made to not have surgery. Knowing
the large size of her tumor, they stated that the surgery would not remove it
all, and could result in deficits including loss of peripheral vision and a potential
weakness on one side of her body. Knowing the importance of quality of life
for Pam, this was the best choice.
All of this happened at a very significant time in Pam’s life — her first daughter’s
		
graduation, getting her moved and settled into college
			
and saying goodbye.

Thankfully, her family and friends stepped up to the plate not only to help her
with the graduation party, but all of the emotions brought on by these new
transitions of life. Pam’s friends and family were a strong support network —
from keeping her busy making a T-shirt quilt for her daughters, to planning fun
visits and dinners to just check in. The overwhelming amount of prayers also
were comforting.
In July 2008, Pam started radiation therapy. “Just like that, the day came that
I had to show up for my first radiation treatment — it was a bad day. Sandy
Johnson, RN, CNS, was my advocate. She already knew my emotions and what
I was feeling. When you walk into the waiting room, you look around and really
realize, ‘Oh my God, I have cancer. Look at all these people who have cancer
too.’ Sandy came out and put me at ease. She made the conversation light and
I was really grateful for her at that painful moment. The radiation staff were
absolutely a great group of people. I saw them for six weeks. They were so
friendly, supportive and timely with results and updates. I was really happy
with all of that,” Pam said.
Pam responded well to the treatments, and did not have a reoccurrence until
April 2014. At this point, she saw Neurologist Kathleen Rieke, MD. “She was
very supportive and extremely knowledgeable. Viewing MRI results with
Dr. Rieke helped me see changes in the tumor,” she said. Pam felt Don Jurgens,
MD, her medical oncologist, did an extraordinary job at compromising and
dealing with her strong-willed personality. He explained how Pam’s type of
brain tumor, oligodendroglioma, is rare and only found in 9.4 percent of brain
cancers. He clarified that because her tumor was very slow growing, her clinical
symptoms outweighed her MRI results, which put her at ease. Chemotherapy
was the next option. After chemotherapy, Pam’s MRI was positive and showed
if anything was left, it was small. Her job going forward was to keep her immune
system in tip-top shape by eating healthy and exercising.
Meditation and prayer both played a significant role in her healing process.
Pam feels a connection to Mother Teresa and reflects on her life often since
one of the miracles which qualified her for Sainthood was curing a person with
a cancerous tumor.
Pam learned many lessons along her cancer journey, but the three most
important were: Number one, “Anyone overwhelmed by illness — pick that
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one person. That one person that’s a good listener, has a good memory and
can absorb the information for you. My greatest support was my husband, Greg.
He reminded me when to eat, take my medications and when I didn’t remember
something, I knew I could rely on him.”
Number two, “Make sure you have a primary care provider. I was very healthy
and did not
have one.
“Diversions are a must throughout this challenging
When I
time. My daughters were my number one diversion.
first left the
They have been a great support, especially in a way
hospital I
didn’t have
that I still need to be a mom to them.”
an advocate
- Pam Schnettler
for me, or
someone
who knew me really well in the medical field, which made it much more
challenging.”
And Number three, “Diversions are a must throughout this challenging
time. My daughters were my number one diversion. They have been a great
support, especially in a way that I still need to be a mom to them. I try to be as
healthy and vibrant as I can so my daughters and family, although concerned, feel
much better. Not only am I a cancer patient, but also a caregiver to my loved
ones around me when it comes down to their emotions and ability to have
hope for me. Diversions are important to make life as normal as possible.”
Pam feels grateful to have a job that she loves surrounded by wonderful
coworkers and friends. As an accounting specialist for CentraCare Health, she
said, “I love what I do — it keeps my quality of life amazing. I still look forward
to coming to the office. I work as much as I can because it leaves less time to
dwell on cancer. I feel good when I am here because it keeps my mind occupied
and I need to exercise my brain.”
This challenging journey has been a life lesson for Pam. It has taught her how to
be more supportive and a better friend to others that also may be struggling in
life. From this experience, she feels very fortunate and realizes how important
a good life is to healing and health … and perhaps even a complete cure.

Erica, Greg, Pam and Jena Schnettler
enjoying some family time in their backyard.
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Relieving Financial Stress
The Coborn Cancer Center has three dedicated staff who work “behind the
scenes” to support our patients through their cancer journey. The patient
financial assistant (PFA) position was created to assist each patient by validating
their insurance coverage for services received at Coborn Cancer Center,
obtaining necessary prior authorizations and connecting them to different staff,
i.e., social worker, to assist with appropriate services for financial assistance.
This service is a value added service to decrease the patient stress by ensuring
their insurance company is properly billed for services received.
Why is it important to have a patient financial assistant? A cancer diagnosis can
be very expensive. It often is a significant source of stress and anxiety for the
patient and his or her family. Some patients report that the practical and
emotional impact is often harder than the medical issues they face.
A newer term in oncology is financial toxicity. This refers to the way out-of-pocket
expenses can drain the wallets of cancer patients, negatively impact their quality
of life and potentially become an adverse event of treatment.
The expense of cancer care goes beyond the treatment and necessary medical
visits; it includes unplanned costs related to transportation/travel, medications
to relieve side effects, extra care needs of family (care giving, at-home care and
long-term care), and potential loss in income due to reduction in work hours.
Our licensed oncology social worker works closely with patients to provide
resources to patients to address many of these concerns.
Cancer patients on average are about 2.5 times more likely to declare bankruptcy
as those without cancer. In fact, 62 percent of personal bankruptcies filed
are due, in part, to a significant amount of medical debt. Of these, 78 percent
had health insurance. In addition, on June 6, 2012, the Star Tribune reported
14 percent of Minnesotans are insured by high deductible insurance plans —
nearly twice the national average.
The patient financial assistants (pictured to the left) are one part of our
talented team behind the scenes supporting the cancer patient along their
trajectory of care. In collaboration with our social worker, they work diligently
to decrease the stress and anxiety related to the financial aspects of medical
care received at Coborn Cancer Center.
(left to right)
Lisa Schmitz, Cancer Center Finance
Rebecca Noska, Cancer Center Finance
Nikki Pullins, Cancer Center Finance
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Diagnostic Imaging
Neuroradiologists are licensed medical doctors sub-specialized in the
radiology practice of diagnosing and characterizing abnormalities of the
central and peripheral nervous system, including the brain, spine and head
and neck regions of the body, using state-of-the-art imaging techniques.
Neuroradiologists utilize their knowledge of anatomy and disease to interpret
these images to make the diagnosis and define the extent of disease, such as
for tumors, cancer treatment effects from chemotherapy and/or radiation
therapy, strokes, aneurysms, genetic conditions, neurodegenerative disease
and many other causes of neurological dysfunction. These state-of-the-art
imaging techniques are implemented to evaluate tissues and blood vessels
of the nervous system, and include:

Tiffany Rickbeil, MD

Chadd McMahon, MD

Internal Medicine,
CentraCare Clinic –
River Campus

Interventional Radiology,
Regional Diagnostic Radiology

Diagnostic Magnetic Resonance Imaging (MRI) methods:
•
•
•
•
•

Contrast-enhanced techniques
Perfusion and diffusion techniques
MR angiography (MRA)
Functional MRI (fMRI)
MR spectroscopy (MRS)

Diagnostic Computed Tomography (CT) methods:
•
•
•
•

Contrast-enhanced techniques
CT angiography (CTA)
Perfusion techniques
Positron Emission Tomography-CT (PET-CT)

Diagnosis of neuropathological processes allow the treating physician —
a neurologist, neurosurgeon, oncologist — to accurately counsel the patient
and start the best therapy at the earliest possible time. This collaborative
approach optimizes patient care and outcomes.
Advancing neuroradiology and improving patient care is a constant focus
of the neuroradiologists at Regional Diagnostic Radiology. Most recently,
the modalities of MR perfusion and functional MRI have been made available
as additional diagnostic techniques in the already advanced neuroimaging
protocols. In some cases, MR perfusion helps to more accurately characterize
tumor burden and/or treatment effects. In other cases, functional MRI is useful
where disease exists in more eloquent regions of the brain, such as areas
responsible for speech or movement. Our fellowship-trained neuroradiologists
continue to play an integral role in the diagnosis and treatment of our patients.

30th Annual Cancer Report | Coborn Cancer Center
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(left to right)
Jerone Kennedy, MD, Neurosurgery
Teri Larson-Johnson, PA-C, Radiation Oncology
Christopher Miller, MD, Radiation Oncology
Amanda Packert, APRN, CNP, Neurosurgery

Neurosurgical Options
for Brain Tumors
For patients with certain types of brain tumors, oncologists
and neurosurgeons may recommend surgical intervention.
The most appropriate initial procedure depends upon the
presumed diagnosis. This presumptive diagnosis is made
after information is considered from the patient’s history,
neurological examination and preoperative diagnostic studies.
These diagnostic studies may provide important information
regarding tumor size, extent and proximity to critical brain
structures. With this information, neurosurgeons are better
able to design surgical approaches that are maximally safe
and effective.
Neurosurgical interventions can range from minimally invasive
procedures for diagnosis, to more lengthy and complex cranial
surgeries for tumor removal. The typical surgical goals are
to confirm diagnosis and remove as much tumor as possible.
For some types of brain tumors, surgical intervention may
be curative. In those cases, subsequent chemotherapy or
radiation therapy may not be necessary. For other types of
brain tumors, surgical intervention may be offered as a way to
delay recurrence of the tumor or to improve quality of life.
At St. Cloud Hospital, the neurosurgical service offers all
standard surgical procedures for brain tumors, as well as
minimally invasive neurosurgical procedures that are not widely
available. As a result of our large volume and long experience
with brain tumors, as well as other complex neurosurgical
conditions, we’ve been designated one of the nation’s
“100 Hospitals and Health Systems With Great Neurosurgery
and Spine Programs” by Becker’s Hospital Review. In addition,
St. Cloud Hospital was ranked third in Minnesota for Neurology
and Neurosurgery by U.S. NEWS and World Report, and was
ranked “Better than expected” for mortality in hospital after
cranial neurosurgery by Healthgrades.
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Symptoms of a Brain Tumor
Symptoms vary greatly and depend on the brain tumor’s size, location and rate
of growth. They may occur gradually and become worse over time, or they can
happen suddenly. Tumors in any part of the brain may cause the pressure inside the
skull to rise. This can be caused by growth of the tumor itself, swelling in the brain
or blockage of the flow of cerebrospinal fluid. The most common symptoms caused
by this increase in pressure and attributed to a brain tumor include headaches,
seizures, muscle weakness in arms and legs and cognitive dysfunction, including
memory problems and mood or personality changes.
A common initial symptom of a brain tumor is headaches. Forty percent of brain
tumor headaches often are accompanied by nausea and vomiting. They tend to be
worse at night and may awaken the patient. Brain tumor headaches tend to get
worse over time, don’t respond to usual headache remedies and occur in about
half of patients. Keep in mind, most headaches are unrelated to brain tumors.
As many as half of people with brain tumors will have seizures at some point. The type
of seizure may depend on where the tumor is located. Sometimes this is the first sign
of a brain tumor, but fewer than one in 10 first seizures are caused by brain tumors.

Types of Brain Tumors
Benign tumors (non-cancerous) and malignant tumors (cancerous) can involve the
brain and spinal cord, as well as the supporting bony skull and spine. Tumors can
arise directly from the brain or spinal cord (primary tumors), or can spread to the
brain or spine from other parts of the body (metastatic tumors).
Benign brain and spinal tumors generally are more slow growing, and tend to be
less invasive. Common types of benign brain tumors include meningiomas, grade I
astrocytomas and acoustic neuromas. Common types of benign spinal tumors
include meningiomas, schwannomas, and intrinsic ependymomas and grade I
astrocytomas. Benign tumors typically are more easily controlled with therapy, and
generally have a lower recurrence rate. Certain benign tumors can be life-threatening
if they compress important brain or spinal structures. Furthermore, some benign
tumors can later change to malignant tumors.
Malignant tumors are considered cancerous. They tend to grow more quickly, tend
to be more invasive and are more likely to spread to other distant structures.
Metastatic malignant brain and spinal tumors most commonly originate from lung,
breast, kidney or skin cancers. Primary malignant tumors of the brain and spinal
cord most commonly arise from supporting glial cells. The most common malignant

brain tumor types include anaplastic astrocytoma (grade III astrocytoma),
glioblastoma (grade IV astrocytoma) and anaplastic oligodendroglioma.
Brain and spinal tumors can present with a wide variety of signs and symptoms.
The clinical presentation is largely dependent on the location and the rate
of growth of the tumor. Patients with tumors close to the areas of the brain
involved in movement or speech can present with deficits in those functions
fairly early in the course of tumor growth. Patients with tumors some distance
from critical brain structures may present with fairly large tumors, but with
few or no neurological deficits. Regardless of tumor location, however, all
patients can be affected by the amount of mass, and the amount of brain
deformity, associated with the tumor. The intracranial space has a fixed volume,
so that gradual increase in volume or mass associated with a tumor may
eventually lead to increased intracranial pressure. Common symptoms
associated with increased intracranial pressure include headache, nausea,
vomiting and double or blurred vision. Patients with tumors involving the
spine can present with complaints of back pain, numbness, weakness, poor
bowel or bladder control and difficulty with walking.
Once a physician has completed a detailed history and an initial assessment
of neurological function, patients are then typically sent for anatomical and
functional imaging studies. These studies are performed to confirm the clinical
suspicion for a brain or spinal tumor. Typical anatomical studies, such as MRI
and CT, can provide crucial information regarding the location of the tumor.
Noninvasive functional studies may provide crucial information regarding the
degree of involvement of critical brain and spinal areas, as well as information
regarding possible risk to those areas during surgery. These studies, in conjunction
with the information gleaned from the patient’s history and neurological exam,
help physicians form a presumptive diagnosis and design the safest initial
treatment plan.
In some situations, a minimally invasive biopsy is then performed to confirm
the diagnosis. In other situations, a recommendation for direct tumor resection
is given. In either case, the subsequent pathological diagnosis will ultimately
determine subsequent therapy and expected survival. Subsequent therapy may
include various combinations of chemotherapy, radiation therapy or further
resective surgery. Eventually, palliative care and hospice services may need to
be offered in order to assist patients and their families with quality-of-life
and end-of-life issues.
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Radiation Therapy
Options for Brain Cancer
Overall incidence of brain tumors has been on the rise since the mid 1900’s. It
is estimated nearly 78,000 new cases will be diagnosed in the U.S. during 2016.
One way brain tumors are treated is with external beam radiation. Radiation
therapy uses high-energy X-ray beams to damage or kill tumor cells by targeting
the cell’s DNA in hopes of stopping tumor growth and help prevent cancer
recurrence. Radiation may be used alone, or in combination with surgery or
chemotherapy.
Depending on the type of radiation used, treatments can last anywhere from
one day to several weeks. Types of external beam radiation include partial or
whole brain, stereotactic, proton beam or brachytherapy.
Currently, whole brain and partial brain radiation are available at Coborn
Cancer Center. Whole brain radiation therapy (WBT) is a type of radiation
used to treat patients whose brain tumor cannot be removed surgically or for
individuals who have multiple brain tumors. An advantage of WBT is the ability
to treat microscopic disease not visible on imaging. This can decrease the risk
of subsequent brain cancer spreading. An individual’s speech, memory, or
processing speed may be affected by WBT which can impact quality of life.
Partial radiation covers a smaller area of the brain. The benefits are the ability
to spare healthy brain tissue with less side effects.

Chemotherapy Options
for Brain Cancer
Patients with brain cancer whose treatment plan includes chemotherapy can
receive this type of treatment several ways. Chemotherapy, which is designed
to kill cancer cells at various stages of growth, can be given orally in a pill form,
through an IV into the blood stream or to the brain tumor site after the tumor
has been removed using a dissolvable wafer.
A type of chemotherapy that is taken orally for brain cancer is Temodar which
often is used with radiation treatment and then continues for a period of time
after radiation is complete. The nursing staff at Coborn Cancer Center provide
education to patients on how to obtain, take and manage side effects related
to oral chemotherapy.
Carmustine, a type of chemotherapy, can be administered into the bloodstream
via an IV or central line. Intravenous chemotherapy is administered by a specially
trained RN in the chemotherapy infusion area at Coborn Cancer Center.
Carmustine also can be used in dissolvable wafers that release the chemotherapy
into the tumor bed and may help prevent the tumor from returning. These
wafers are placed in the tumor bed by a surgeon.

Significant progress has been made with brain tumor treatments to improve
patients’ quality of life and survival. As technology continues to evolve in the
field of radiation oncology, we are constantly presented with the opportunity
to be forward thinking on how these advancements can improve our
patients’ lives.

Another type of therapy is targeted therapy such as a monoclonal antibody
where antibodies are grown in a laboratory and administered to the patient
through an IV. These antibodies identify proteins on cancer cells that are
involved in cell growth and attach to these proteins to prevent the cancer
cells from growing. A monoclonal antibody that is used for recurrent brain
cancer is Avastin (bevacizumab). This monoclonal antibody binds to a protein
called vascular endothelial growth factor (VEGF) which prevents the production
of new blood vessels. This prevents the tumor from growing and deprives the
tumor of blood supply.

We are working to bring stereotactic radiosurgery (SRS) to our cancer program.
SRS delivers higher doses of radiation to the tumor with precise accuracy to
destroy the cancer while preserving the surrounding healthy brain tissue. In
addition, SRS minimizes the risk for side effects, including memory loss, which
leads to a better long-term outcome and improved quality of life.

Patients also may elect to participate in a clinical trial. A treatment clinical trial
may be designed to improve current treatments or study new treatments for
patients which then could become the standard of care. Other studies look
at better management of side effects which improves that patient’s ability to
receive effective cancer treatment.
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Clinical Research
Coborn Cancer Center offers a clinical trial
research program as part of their commitment
to advance the care of patients. Each new
patient is screened and any potential trials
are shared with his or her physician. The
research team includes certified registered
nurses, clinical research associates and
a physician investigator with extensive
education in research methods, treatment
options and patient rights. At any given time,
there are approximately 40 clinical trials open
for individuals with many types of cancer.
The research department typically has
one to two research trials available for
patients with brain tumors. Coborn Cancer
Center is active in protocols set forth by
the National Cancer Institute as well as
industry-driven trials. These protocols
focus on offering new therapies, reducing
side effects from treatment and improving
quality of life. We are appreciative of those
patients who participate in trials, as they
often improve care for future patients.
(standing left to right)
Don Jurgens, MD, Hematology/Oncology,
Principal Investigator
Cheryl Kelley, Clinical Research
(sitting left to right)
Stacy St. Onge, BSN, RN, OCN, Clinical Research
Stacey Nistler, Clinical Research
Katie Greb, BSN, RN, OCN, Clinical Research
Judy Jensen, BSN, RN, OCN, Clinical Research
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Palliative Care and Brain Cancer
A diagnosis of brain cancer is shocking and devastating to patients and families.
Brain cancer is frequently diagnosed in late stages with dramatic symptoms
present at diagnosis. Patients and families are overwhelmed by the impact the
diagnosis has on their function and quality of life. Palliative care is helpful in
assisting patients and families in addressing and voicing their goals and wishes,
treating symptoms and facilitating advance care planning.
Palliative care is a medical specialty that focuses on the physical, emotional and
spiritual needs of people with serious illness. The goal is to reduce suffering,
protect dignity and improve quality of life for patients and families. This care
can take place at the same time as other treatments and at any time during
a serious illness. Care is provided in a holistic manner that addresses all the
needs of patient and family, even beyond the medical needs.
At Coborn Cancer Center, palliative care is incorporated into the care of
all patients. Two levels of palliative care exist: generalist and specialist palliative
care. Generalist palliative care is care provided for those affected by serious
illness as an integral part of standard clinical practice by any health care
professional who is not part of a specialist palliative care team. Generalist
palliative care includes management of pain and symptoms, management of
depression and anxiety, discussions about prognosis, goals of treatment, suffering
and code status, and advance care planning. Specialist palliative care is care
provided by those who have undergone specific training and/or accreditation in
palliative care medicine, working in the context of an expert interdisciplinary
team of palliative care health professionals. Specialist palliative care practice
builds on the palliative care provided by generalist providers and reflects a
higher level of expertise in complex symptom management, spiritual support,
psychosocial support, cultural support and grief and loss support.
The oncology staff at Coborn Cancer Center assess patients and families
frequently for palliative care needs. All patients undergoing care at Coborn
Cancer Center receive generalist palliative care provided by their oncology team.
If more complex palliative care needs are identified, the oncology staff will place
a referral for the patient and family to see one of the palliative care specialists
at Coborn Cancer Center. Patients and families also may access palliative care
while hospitalized at St. Cloud Hospital through a referral to the inpatient
interdisciplinary palliative care team. Some patients also may receive home
palliative care services through CentraCare Health Home Care & Hospice.
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An interdisciplinary palliative care team adds an extra layer of support
at home to patients living with serious illness to ensure quality of life despite
the challenges of the illness.
Palliative care can play a vital role in the care of patients with brain cancer,
regardless of the stage of diagnosis. Many patients with brain cancer experience
symptoms including headaches, seizures, fatigue and mood changes. With
successful management of these symptoms, patients ideally are able to more
fully participate in and enjoy daily life. Early involvement of palliative care can
improve the ability to tolerate medical treatments and can help patients better
understand treatment choices, which often allows them to feel an enhanced
sense of control around their medical care.

More, Better, Earlier Conversations
As health care and technology evolve, people are living longer often with one
or more serious illnesses. Although interventions exist to extend life for people
with serious illness, sometimes these interventions negatively impact quality of
life and may not align with personal goals. Research has proven that a gap exists
in current health care between what people living with serious illness want in
regard to their health and what they actually receive. For example, 86 percent
of Medicare beneficiaries have identified that their preference is to die in their
home when almost 40 percent will die in an acute care hospital. People with
serious illness have identified priorities other than living longer such as symptom
management and quality of life, a sense of control and completion and
strengthened relationships. One of the key reasons this gap exists is because
the conversations necessary between health care providers and people living
with serious illness don’t occur often enough, and if they do occur, it frequently is
within the last months to days of life. Several barriers contribute to the delay in
these conversations including lack of health care provider training and confidence,
perceived time constraints and the lack of value for these conversations within
the culture of medicine. Patient and family barriers also exist including reluctance
to initiate discussion about goals and wishes especially if it contradicts the
recommendations of the health care provider. The bottom line is that multiple
factors impede meaningful conversations.
CentraCare Health and Coborn Cancer Center are committed to delivering
the kind of health care that people living with serious illness want. In order
to do that, we first have to ask patients about their goals and priorities.

A program currently is in development
within CentraCare Health, focusing on
improving the skills and training of primary
and specialty health care providers to carry
out goals-of-care conversations with
seriously ill patients. The goal of this program
is to improve the lives of all people with
serious illness by increasing meaningful
conversations about their values and
priorities utilizing a systematic approach.
Health care providers are trained in the use
of the Serious Illness Conversation Guide*,
which provides a structure and language
to facilitate robust conversations between
health care providers and people living with
serious illness. The information obtained
about the patient’s goals and wishes are
documented in the patient’s medical record
and are available to all providers caring for
the patient. This ensures that regardless
of where the patient is receiving care, their
goals and priorities are accessible and
acknowledged. Over the next fiscal year,
the goal is continue disseminating this
program throughout CentraCare Health.
* © 2015, Ariadne Labs: A Joint Center for Health Systems Innovation
(www.ariadnelabs.org) and Dana-Farber Cancer Institute. Licensed
under the Creative Commons Attribution-NonCommercial-Share
Alike 4.0 International License, http://creativecommons.org/
licenses/by-nc-sa/4.0/

(left to right)
Kris Gross, APRN, CNP, Palliative Care
Sara Revier, APRN, CNS, Palliative Care
Paula Lindhorst, MD, Palliative Care
Merryn Jolkovsky, MD, Palliative Care
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Clinical Ladder IV Nurses
(standing left to right)
Roland Brummer, RN, OCN, Inpatient Oncology		
Amy Bianchi, BSN, RN, OCN, Chemotherapy and Infusion
(sitting left to right)
Melissa Nagengast, BSN, RN, OCN, Chemotherapy and Infusion
Jill Libbesmeier, BSN, RN, OCN, Inpatient Oncology		

Oncology Nursing
Oncology nursing care is provided at Coborn Cancer Center and the Inpatient
Oncology Unit at St. Cloud Hospital. In partnership with Coborn Cancer
Center, oncology care also is provided at regional sites in Central Minnesota
under the direction of Coborn Cancer Center medical and radiation oncologists.
These sites include Alexandria, Glenwood, Little Falls, Long Prairie, Melrose,
Monticello, Paynesville and Sauk Centre. Nursing care is provided by registered
nurses, licensed practical nurses and nursing assistant/patient care assistants.
The following is a summary of the nurses’ preparation to provide an exceptional
patient care experience for our oncology patients.
Education Preparation (St. Cloud Campus* only)
• Direct Care RNs with baccalaureate
or higher degree in nursing
• Number of advanced practice RN’s

79%
4

National Certification of Direct Care Staff (St. Cloud Campus* only)
NDNQI Benchmark: 33.64% (90th percentile)
• Inpatient Oncology
51%
• Outpatient Oncology
77%
Oncology Nursing Society Specialty Training Completion
• Chemotherapy/Biotherapy Certificate Course (inpatient)
• Chemotherapy/Biotherapy Certificate Course
(outpatient/regional sites)
• Radiation Therapy Certificate Course

89%
98%
100%

* St. Cloud Campus: Coborn Cancer Center, Inpatient Oncology Unit at St. Cloud Hospital

Why do oncology nurses become certified?
Oncology nursing certification is a formal recognition of specialized knowledge,
skills and experience. Certification helps develop specialty nursing by creating
minimum competency standards for the care of the oncology patient. Regardless
of the health care setting, certification benefits patients and their families, nurses
and employers. Oncology nursing certification validates that nurses have met
stringent requirements for knowledge and experience and are qualified to
provide competent oncology care.
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St. Cloud Hospital demonstrates their commitment to providing the highest
quality of care to patients with cancer throughout the health and illness
continuum by hiring certified nurses, supporting nurses in attaining and
maintaining certification, rewarding nurses who become certified and informing
patients and the public about the certification status of their nursing staff.
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(Information from the Oncology Nursing Certification Corporation at oncc.org.)

Oncology Nurses in the Spotlight
Awards & Recognitions
Daisy Award
Amy Stolt, RN, BSN, OCN, Women’s Care Coordinator
March of Dimes Oncology Nursing Nominee
Amanda Zierden, BSN, RN, OCN, Medical Oncology Clinic
Outstanding Achievement in Use of Evidence in Nursing Management
Catherine Tieva, BSN, RN, PHN, OCN, Radiation Oncology
Outstanding Achievement in Mentorship
Sara Revier, MSN, RN, ACNS-BC, ACHPN, Palliative Care
Outstanding Support to Enhance the Process of Evidence-Based Practice
or Nursing Research Award
Joy Plamann, BSN, MBA, RN, RN-BC, Inpatient Medical Oncology
Publications in 2015
Jane Vortherms, MHA, RN, OCN, Brenda Spoden, BSN, RN, OCN, CRNI,
and Jill Wilcken, BSN, RN, OCN (2015). From Evidence to Practice: Developing
an Outpatient Acuity-Based Staffing Model. Clinical Journal of Oncology Nursing,
19 (3), 332-337.

“Oncology nurses have a sacred
profession, one that utilizes
specialized training to care for the
body, mind and spirit of cancer
patients and their families.”
- Catherine Tieva, BSN, RN, PHN, OCN,
		 Radiation Oncology

Exemplary Professional Practice –
Evidence-Based Practice
Inpatient Medical Oncology Practice Improvement Project
Cancer patients may be at higher risk to develop infection. This risk increases if
the patient has a urinary catheter or a central venous catheter (such as a PICC
or port). In efforts to reduce the risk of infection for hospitalized patients, the
Inpatient Medical and Oncology Unit implemented bathing with chlorhexidine for
patients who have a urinary catheter or central venous catheter. Chlorhexidine has
antimicrobial cleaning and protection above normal soap and research has shown
a reduction in infection with daily use. Patients can clean with chlorhexidine
as a solution in the shower or wipes if limited to bed. Since implementation of
bathing with chlorhexidine, we have experienced no infections associated with
urinary catheters and a reduction in central line associated infections.

Interdisciplinary Chemotherapy Teaching
Patients can be overwhelmed with information before they start treatment.
Prior to this project, patients and their families were invited to attend a group
class to learn about chemotherapy. The networking between patients was good,
however, it was difficult to customize the class to each patient. An interdisciplinary
group reviewed content, defined expectations and revised the class to provide
individualized patient education. Patients now are scheduled for a two-hour
education session to meet with a registered nurse, pharmacist, social worker
and dietitian. Overall, patient satisfaction reflects an improvement in patients’
understanding of side effect management and feeling less overwhelmed. Through
the team effort, we can better provide an exceptional and individualized care
experience for our patients.

Exemplary Professional Practice –
Nursing Research
An internal nursing research study was designed to measure breast cancer
patient decision making and satisfaction addressing hair loss when receiving
adjuvant chemotherapy. A prospective single center descriptive study will
compare decision making and satisfaction for subjects who select cooling before
chemotherapy, then every month for three months and finally six months after
the last cytotoxic chemotherapy. The data is being analyzed from the 44 patients
who enrolled in the study. One early outcome of the study is nursing staff
provide consistent education to patients regarding potential for hair loss and
options available to prevent or address temporary hair loss.
30th Annual Cancer Report | Coborn Cancer Center
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Integrative Therapy
Benefits Patients
Kathi Sowada, MSAOM,
MSN, RN, LAc, HN-BC
Integrative Therapies Specialist,
St. Cloud Hospital

Oncology patients now have access to evidence-based integrative therapies
to manage symptoms and promote wellness during their healing journey. An
RN integrative therapies specialist leads the efforts to promote and provide
integrative services to patients and to educate nursing staff, providers and
patients on the benefits and use of these modalities.
Integrative therapies are therapeutic, non-pharmacological treatments that
support health and healing by promoting balance in body, mind and spirit. They
are safe and work in harmony with standard medical care. Patients are offered
these services as an adjunct to their regular medical regime. Because integrative
therapies are holistic modalities, practitioners take into consideration a person’s
emotional and spiritual state, as well as the condition of the physical body.
These therapies can affect a person on all levels, and therefore can help with
a wide range of conditions or symptoms. Most commonly, they are used to
enhance the healing process and deal with the common side effects of cancer
treatment such as nausea, pain, fatigue or peripheral neuropathy. However,
they also can be used for mental-emotional concerns, such as depression,
anxiety, stress or difficulty coping with illness. Because they work by stimulating
the body to heal itself, they also can be used to promote wellness and
prevent illness.
Integrative therapies available include aromatherapy, Healing Touch, acupuncture,
acupressure and Animal-Assisted Therapy. Nurses in both the chemotherapy
infusion and radiation oncology areas have been trained in aromatherapy
and the use of four essential oils that are effective in symptom management:
lavender, spearmint, ginger and sweet orange. Aromatherapy can be requested
by patients at any time during their cancer treatments and can help with nausea
or discomfort and promote relaxation. Acupuncture, acupressure and Healing
Touch are available by appointment after a referral is placed by the nurse or
physician. These treatments are used alone or in combination, and can assist
with many physical and emotional concerns affecting those dealing with cancer.
Additionally, Animal-Assisted Therapy pets and their volunteer handlers visit
with patients in the waiting areas or treatment rooms to promote social
and emotional well-being.
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The use of these evidence-based integrative therapies in the outpatient
oncology setting can help improve the patient experience, improve health
outcomes and decrease the amount of medication used for symptoms such
as pain, anxiety and nausea.

Building a Foundation
for Cancer Survivors
When the words “cancer” and “you” are tied together into one
sentence — this challenging new reality can consume our body,
our mind and our spirit. Coborn Cancer Center is offering hope
to cancer patients, whose survivorship journey not only begins the
day of their diagnosis, but continues into their new reality — life post
treatment. Patients have voiced their concerns, telling us how supported
they felt when receiving the physical treatments, chemotherapy or
radiation, and how lost they felt when the treatments were over and
they were sent back to their lives feeling anxious, isolated and unsure
of the road ahead.
Coborn Cancer Center is taking great strides to illuminate these
shadows, and we need your help. Our vision is to create a separate,
refreshing space adjacent to Coborn Cancer Center where healing
opportunities come in many forms. A place where integrative therapies
such as mindfulness, yoga and Healing Touch help build resiliency,
massage therapy and acupuncture ease muscle and joint pain, art
and music therapy calm restless thoughts and support groups help
connect and console. All of this in a comforting space dedicated
to our patients’ well-being.
Undertaking a sizeable project such as this needs community support.
The Coborn Family Foundation has generously donated a $1-million
gift to aid in establishing this space which offers a whole new level
of support to cancer patients and caregivers. This 100 percent donorfunded survivorship center will cost $3.2 million, so additional funding
is needed.

Your gifts matter
Our community of survivors needs their community — YOU — to
understand that “living with cancer” can be as challenging as being
diagnosed with cancer. A building dedicated to meeting all the needs
of our patients is everyone’s responsibility to make a difference.
If you want to be part of this amazing effort, please contact Luan Knoll,
CentraCare Health Foundation, at 320-654-3687 or visit
www.centracare.com/foundation.

Emily Coborn
Vice president of Fresh Merchandising
and president of the Coborn Family
Foundation
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Surviving with Faith
The American Cancer Society describes three distinct phases associated with cancer survival,
including the time from diagnosis to the end of initial treatment, the transition from treatment
to extended survival and long term survival. Cancer survivorship is a dynamic process of living
with, through and beyond a diagnosis of cancer, regardless of the outcome. Many organizations,
including the Institute of Medicine, Commission on Cancer and the American Society of Clinical
Oncology’s Quality Oncology Practice Initiative, have emphasized the importance of survivorship
and ensuring patients and primary care providers are given a summary of treatment and a follow-up
care plan after completion of their active treatment. In 2015, Mary Weis, RN, APRN-CNS, was hired
at Coborn Cancer Center to refine our process and increase patients’ access to survivorship visits.
Below is one patient’s story of the visit.

As the dean of the School of Theology and Seminary at Saint John’s University
in Collegeville, Bill Cahoy had taken to heart the monastic mantra to “keep death
daily before your eyes — be prepared.” After a large-massed tumor was discovered
in his colon at age 60, Bill’s prayer wasn’t just to not die, “My prayer was to not
die because of my own stupidity by not getting a colonoscopy,” he said. “I’ve spent
my life fighting the consequences of ignorance.” After teaching others for 34+ years
about the true depth of life, Bill quickly got to experience his wisdom first-hand.
Bill’s symptoms were not blatant. There was no blood in his stool or abdominal pain.
His symptoms were fairly common — weight loss and feeling run down. “I assumed
this is what it’s like to be 60,” he said. Bill was scheduled to do a lecture in Portland
when he noticed a scratchy throat. He went in for a strep test to get on antibiotics
and clear it up in time for his trip. However, the strep test came back negative.

Bill and Jennifer
Cahoy taking
a break out
of their busy
work day at
Saint John’s
University.
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After visiting Chris Wenner, MD, at CentraCare Health Paynesville – Cold Spring
Clinic, his hemoglobin tests came back extremely low. Bill had a CT scan on a
Tuesday, was admitted to St. Cloud Hospital Wednesday, with a colonoscopy
scheduled for Thursday. Friday morning he had surgery where they removed one
third of his colon. His surgeon, Stephen Sahlstrom, MD, said his grapefruit-sized
tumor had been there for a long time. Luckily, his body created an abscess around
the tumor encasing it from spreading to the rest of his body. After his 10-day
hospital stay, Bill went home 30 pounds lighter. His main job was to eat and rest.
“My wife likes to cook and I really like to eat, so that works out,” he laughed.
After starting chemotherapy in April 2015, Bill experienced fatigue and neuropathy.
“My chocolate and red wine just didn’t taste as good,” he joked. To help fight his
fatigue and keep his spirits up, Bill made sure to exercise regularly using his elliptical
and free weights. He didn’t let his chemo pump get in the way — not even during
his first few weeks back to teaching in the fall.

Bill has felt amazingly blessed with tremendous support throughout this unexpected
journey. His wife, Jennifer, has been there for him not only daily and with every
appointment, but hourly and always with great cheer. Spending time with his children
and grandchildren has been uplifting. The support and accommodations from Saint
John’s University and his fellow staff was very heartening and helpful throughout his
struggle. “I will never forget waking up in the hospital with one of my friends sitting
next to me,” he said. “Or receiving homemade pudding to enjoy, getting a package
full of boxes from a friend — one box for
each upcoming chemo treatment, visits from
“Once my treatment was over, the support
work friends, friends volunteering to mow
offered by Coborn Cancer Center was not over.
my lawn and prayers. People praying for me,
My survivorship visit was incredibly helpful.”
here, and all over the country. I felt lifted up.
- Bill Cahoy
All of the love and support out there — it
was an incredibly moving experience.”
When asked what stood out the most, Bill stated, “My experience with
Coborn Cancer Center was unfailingly positive. To me, it captures the spirit of
the whole place and how patient-centered it truly is. The nursing staff is awesome,
just incredible. They do the real work of patient care, and they are amazing.
The chemo infusion staff was tremendous — I felt very well-cared for. My surgeon,
Dr. Sahlstrom, was phenomenal — I can hardly see my scar,” he laughed. “I liked
Dr. Jurgens’ style — it clicked with me. He was very knowledgeable and
experienced. Everyone just really paid attention to me and my needs here.”
“Once my treatment was over, the support offered by Coborn Cancer Center was
not over. My survivorship visit was incredibly helpful,” Bill remembers, “I had questions
pertaining to my surgery and where I’m at now. This visit works through that
entirety from beginning to end, wrapping up all of those loose ends. I appreciated the
knowledge and being informed on what was available — it was a good experience.
There may be needs going forward. To know this support is there, is a gift.”
Bill described, “Coming face-to-face with his own finitude” as being his toughest
challenge. “People say you need to listen to your own body,” he said. “However,
I always lived with the idea that my body needed to listen to me. I have always
been in charge — my strength of will. However, it became clear that at a certain
point, my body just said ‘No.’ Coming to terms with that and limitations on what
I could and couldn’t do was a struggle. I have learned a lot throughout this journey.
I’m still unpacking what I’ve learned from all of this. My first and last message for
everybody — get your colonoscopy.”
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Glioblastoma Multiforme Study

# OF CASES

Throughout the past 10 years there has been a 62 percent increase in
overall new brain tumor diagnoses. Graph 1 illustrates all new brain tumors
diagnosed and/or treated at St. Cloud Hospital, irrespective of histology, in a
10-year period.
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the brain rather
than having spread there from a different part of the body. There are more
than 120 types of primary brain tumors.
Treatment of brain tumors depend on the nature of the tumor, how rapidly
it is growing, what symptoms it is causing and where it is located. No current
treatment for GBM is curative. Standard treatment consists of maximal surgical
resection, radiation therapy, concomitant and adjuvant chemotherapy.
An estimated one out of every four patients with this type of tumor survives
two years. Prospects are better when the patient is younger than 45, all or
most of the tumor can be removed and the tumor turns out to be an anaplastic
astrocytoma, which is one stage less severe than GBM.
In 2015, the Cancer Care Center Board approved an in-depth review of
patients diagnosed with Glioblastoma Multiforme between January 1, 2013
to June 30, 2015 to review compliance with current National Comprehensive
Cancer Network® (NCCN) guidelines. There was a total of 26 patient
records reviewed by Girum Lemma, MD and Mary Weis, MSN, APRN-CNS.
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The selection criteria to include patients in the study was straight forward —
patients who received all of their treatment at St. Cloud Hospital or Coborn
Cancer Center.

SCH
NATIONAL

Graph 2 displays the total number of brain tumors diagnosed during the study
period (January 1, 2013 to June 30, 2015), broken down by histology. The
chart demonstrates consistency with the literature in that the most common
malignant
Graph 2
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Treatment:
It is recommended that
Anaplastic Astrocytoma
all high-grade
gliomas
have either
a resection
when determined to be feasible or a stereotactic/open biopsy. The decision is
made while carefully considering patient safety and outcome. This is followed by
radiation therapy and/or chemotherapy depending on the patient’s performance
status. If the patient’s performance status is poor, the patient will be referred to
palliative care or hospice. The 26 patients reviewed demonstrated 100 percent
(15/15) compliance for those who were treated. All the remaining patients,
100 percent (11/11) were referred to palliative care or hospice.
Follow-up Imaging: Twenty-five of the patients (96 percent) underwent a
surgical resection. It is recommended that a brain MRI be completed within
24-72 hours after surgery. The 25 patients reviewed demonstrated a 28 percent
(7/25) compliance rate to this guideline. An additional recommendation is to

have an MRI completed two to six weeks after
radiation therapy, and then every two to four
months for up to three years. Of the 15 cases
who had radiation therapy, 100 percent (15/15)
compliance was demonstrated.
Methylguanine DNA methyl-transferase (MGMT)
Promoter Status: If the patient has a Karnofsky
Performance Status (KPS) greater than 60, it is
recommended this testing be completed. When
the test is positive, recommendations reflect
use of Temozolomide. This test is not routinely
completed at St. Cloud Hospital, thus resulting
in a 0 percent compliance with this guideline.
All data was reviewed by the Cancer Care Center
Board. It was decided to continue the current
practice regarding not testing for the MGMT
and to focus on the patient performance status
and ability to tolerate Temozolomide. An area of
concern identified was obtaining a post-operative
MRI within 72 hours of resection per NCCN
guidelines. The cancer liaison physician met
with the Neurosurgery department to share
the study results.
The Cancer Care Center Board requested a
follow-up review of cases in 2016 to assess impact
of recommendations as part of their quality
improvement efforts. There were four cases
reviewed who were diagnosed and treated
between April-June 2016. The results of this
follow-up demonstrated 100 percent compliance
with obtaining a post-operative MRI within
72 hours of resection, per NCCN guidelines.
(left to right)
Janet Sather, RHIA, CTR, Cancer Registry
Jodi Kreutz-Gratke, Cancer Registry
Heidi Leach, RHIT, CTR, Cancer Registry
Girum Lemma, MD, Hematology/Oncology
Melissa Shankey, RHIT, CTR, Cancer Registry
Jessica Klaphake, RHIT, CTR, Cancer Registry
Candace Schoolmeesters, RHIT, CTR, Cancer Registry
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Clinical Achievements
Coborn Cancer Center is nationally recognized for its dedication to quality.
Our professionals are committed to providing patients with exceptional
outcomes based on adherence to best practice standards, multidisciplinary
coordination of care, shared decision-making, access to leading cancer
providers, research and clinical trials and continued adoption of new
technologies, services and programming.
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Some examples of our recognized quality include:
St. Cloud Hospital Magnet Designation
Magnet designation is the highest international
recognition for excellence in the provision
of nursing services, quality patient care and
innovation in professional nursing practice.
St. Cloud Hospital has been Magnetdesignated since 2004.

Commission on Cancer Certificate of
Accreditation with Commendation
In 2013, Coborn Cancer Center received
a three-year approval with Commendation
and an Outstanding Achievement Award
as a Community Hospital Comprehensive
Cancer Program from the American College
of Surgeons Commission on Cancer. Coborn
Cancer Center, a service of St. Cloud Hospital,
has been accredited by the Commission on
Cancer since 1989.

Member of the Mayo Clinic
Cancer Care Network
As part of the cancer care network, Coborn Cancer Center physicians have access
to Mayo Clinic’s evidence-based protocols, clinical care guidelines and reference
materials, as well as eConsults. Our selection
as a Mayo Clinic Cancer Care Network
member was based on a rigorous set of
quality and service criteria.
Patients and their families can be assured that Coborn Cancer Center shares
with Mayo Clinic a commitment to continually improve all aspects of health care.
The primary goal of the network is to help people gain the benefits of Mayo Clinic
expertise while receiving care closer to home.

The fight against cancer is stronger.
Coborn Cancer Center already is a regional cancer center of the highest quality with
program certification of commendation and outstanding achievement by the American
College of Surgeons Commission on Cancer. Mayo Clinic is a National Cancer
Institute-designated cancer center, committed to serving patients and collaborating
across the full spectrum of cancer research, from basic biology to treatment.
We have enjoyed a longstanding working and referral relationship with Mayo Clinic,
including research programs for patients interested in cancer-based clinical trials.

